Field Trip Health Ltd. (FTRP)

Field Trip Health Ltd. (NASDAQ:FTRP ) Q1 2023 Earnings Conference Call August 16, 2022 8:30 AM ET Company Participants Kathleen Heaney - KCSA Strategic Communications Ronan Levy - Chairman and Chief Executive Officer of Field Trip Health & Wellness Joseph Del Moral - Chairman and Chief Executive Officer Donna Wong - Chief Financial Officer Nathan Bryson - Chief Scientific Officer Conference Call Participants Andrew Partheniou - Stifel Nicolaus Patrick Trucchio - H.C.

Field Trip Health Ltd. (NASDAQ:FTRP ) Q4 2022 Earnings Conference Call June 30, 2022 8:30 AM ET Company Participants Kathleen Heaney - Investor Relations Joseph Del Moral - Co-Founder and Chief Executive Officer Ronan Levy - Co-Founder and Executive Chairman Donna Wong - Chief Financial Officer Paula Hewitt - Vice President and General Counsel Nathan Bryson – Chief Scientific Officer Conference Call Participants Andrew Partheniou - Stifel Patrick Trucchio - H.C.

The three major U.S. equity indexes closed lower Monday, with the Nasdaq dipping by 0.72%, the S&P 500 sliding 0.3% and the Dow Jones industrials closing down 0.2%.

TORONTO, June 23, 2022 (GLOBE NEWSWIRE) -- Field Trip Health Ltd. (TSX: FTRP, FTRP.WT, Nasdaq: FTRP) ("Field Trip"), a global leader in the development and delivery of psychedelic therapies, announced today that Field Trip's Co-founder and Executive Chairman, Ronan Levy, and Chief Scientific Officer, Dr. Nathan Bryson, will participate in a live fireside chat at the H.C. Wainwright 1st Annual Mental Healthcare Conference taking place June 27, 2022.

- Discloses Receipt Of Nasdaq Non-Compliance With Minimum Price Notice - Discloses Receipt Of Nasdaq Non-Compliance With Minimum Price Notice

TORONTO, April 29, 2022 (GLOBE NEWSWIRE) -- Field Trip Health Ltd. (TSX: FTRP, FTRP.WT, Nasdaq: FTRP) ("Field Trip"), a global leader in the development and delivery of psychedelic therapies, announced today that Field Trip's management team will participate in two investor conferences in May 2022.

TORONTO, April 18, 2022 (GLOBE NEWSWIRE) -- Field Trip Health Ltd. (TSX: FTRP, FTRP.WT, Nasdaq: FTRP) ("Field Trip"), a global leader in the development and delivery of psychedelic therapies, announced today that Field Trip's management team will participate in the following investor conferences in April 2022.

Field Trip Health Ltd. (FTRP) CEO Joseph Del Moral on Q3 2022 - Earnings Call Transcript

Psychedelics-based company Field Trip Health Ltd. (TSX:FTRP) (NASDAQ:FTRP) reported its third fiscal quarter 2022 results for the three months ended December 31, 2021 and provided a business update.

Media company Global Trac Solutions, Inc. (OTCP:PSYC) and authorities behind psychedelic news and information platform Psychedelic Spotlight, announced that Psychedelic Spotlight will host its first “CEO Roundtable” on Feb. 15. The event is scheduled to be streamed live on YouTube via The Psychedelic Investor channel, and will be moderated by James Hallifax, journalist and content director for Psychedelic Spotlight.

TORONTO, Feb. 01, 2022 (GLOBE NEWSWIRE) -- Field Trip Health Ltd. (TSX: FTRP, FTRP.WT, Nasdaq: FTRP) ("Field Trip"), a global leader in the development and delivery of psychedelic therapies, announced today that it plans to release financial results for the fiscal third quarter ended December 31, 2021, after market close on Tuesday, February 15, 2022.

On Tuesday, three public companies in the psychedelics/biotech space announced significant milestones in their drug development pipelines. Field Trip Receives Notice Of Patent Allowance For Proprietary Psychedelic Molecule Field Trip Health (NASDAQ:FTRP) received a notice of allowance for a US patent application covering FT-104, its flagship psychedelic drug candidate.

TORONTO, Jan. 05, 2022 (GLOBE NEWSWIRE) -- Field Trip Health Ltd. (TSX: FTRP, FTRP.WT, Nasdaq: FTRP) ("Field Trip"), a global leader in the development and delivery of psychedelic therapies, announced today that Field Trip's Co-Founder and CEO, Joseph del Moral, and Chief Scientific Officer, Dr. Nathan Bryson, will participate in a virtual fireside chat at the H.C. Wainwright Bioconnect Virtual Conference taking place January 10-13, 2022.

Psychedelic substances are often grouped together with cannabis, but there are some important distinctions. ATAI, CMPS and FTRP are some of the best stocks in the space.

The usage of psychedelics like psilocybin, LSD, ketamine, and others are becoming more mainstream, especially with the initial steps to legalization getting moving across a number of states in the U.S. As a result, the psychedelics market is projected to grow 12.4% annually, reaching $10.75 billion in 2027.

TORONTO, Dec. 01, 2021 (GLOBE NEWSWIRE) -- Field Trip Health Ltd. (TSX: FTRP, FTRP.WT, Nasdaq: FTRP) ("Field Trip"), a global leader in the development and delivery of psychedelic therapies, announced today that management will present at H.C. Wainwright's 2nd Annual Psychedelics Conference and Stifel's 2nd Annual Future of Healthcare Conference in December.